APOE promoter polymorphisms and dementia in the elderly

Area of Science:

• Genetics
• Neuroscience
• Gerontology

Background:

• Apolipoprotein E (APOE) promoter polymorphisms, specifically -219 G/T and -491 A/T, have been implicated in dementia risk.
• Previous studies suggested a role for these polymorphisms, necessitating further investigation in independent populations.

Purpose of the Study:

• To investigate the association of APOE promoter polymorphisms (-219 G/T and -491 A/T) with dementia and Alzheimer's disease (AD) risk in elderly populations.
• To determine the independent contribution of these polymorphisms, considering the influence of the APOE e4 allele.

Main Methods:

• Analysis of two independent elderly cohorts (mean age 84-85 years).
• Genotyping of APOE promoter polymorphisms (-219 G/T, -491 A/T) and coding polymorphisms.
• Statistical analysis including odds ratios (OR) and confidence intervals (CI) to assess risk association.
• Haplotype estimation combining promoter and coding polymorphisms.

Main Results:

• The -219T allele was significantly associated with an increased risk of dementia (OR = 1.9) and AD (OR = 2.0) in the elderly.
• The -491 A/T variant showed no significant association with dementia risk.
• The haplotype -491A/-219T/4 demonstrated a substantial risk for dementia development (OR = 3.5), while -491A/-219G/4 did not.

Conclusions:

• The -219 G/T polymorphism acts as an independent genetic determinant for dementia in the elderly.
• These findings highlight the specific role of the -219 G/T polymorphism in dementia pathogenesis, irrespective of the APOE e4 allele status.